Treatment

  • Treatment is by intramuscular (IM) or subcutaneous (SC) injection of the GcMAF-Forte macrophage activating factor, 1 time a week (or as prescribed by the treating physician). See the dosing recommendations below.
  • Treatment in our clinic has also been by intramural (IT) injection although IM and SC injections are by far the most common method of administration.
  • Good aseptic handling is required when using the vials.

Dosing Recommendations for GcMAF-Forte

  • Dosage and frequency of GcMAF-Forte administration are at the discretion of the treating physician.
  • No upper limit has been established for GcMAF-Forte.

Cancer, HIV / AIDS, Hepatitis, Tuberculosis

For patients with cancer, HIV AIDS, hepatitis and tuberculosis, we suggest High-Dose GcMAF-Forte once a week.
GcMAF-Forte-Treatment
  • For maximum effect we recommend 2 ml once weekly.
  • One course of High-Dose GcMAF-Forte is usually 10 doses for 10 Weeks. Additional courses may be required depending on the stage of the disease and the severity of the symptoms.
Macrophage activation is always required for an effective functioning of the immune system. GcMAF-Forte therapy should continue as long as the disease is present and for a period afterwards to reduce the chance of recurrence.
  • Improvements in symptoms should be observed within 2 months.
  • The minimum treatment course is 10 weeks but each patient is different and additional courses may be required based on positive progress.
  • Patients may need long-term maintenance doses of GcMAF-Forte therapy to stay well and symptom-free until their immune system is fully recovered to cope with any challenge.
* Note that these dosage recommendations apply only to IMMI GcMAF-Forte.

Autism Spectrum Disorders (ASD)

Recommended dose – 2ml High-Dose GcMAF-Forte once weekly by subcutaneous injection.
  • Some improvements in symptoms should be observed within 2 months.
  • The minimum treatment course is 10 weeks but each individual patient is different and additional courses may be required based on positive progress.
  • Patients may need long-term maintenance doses of GcMAF-Forte therapy to stay well and symptom-free until their immune system is fully recovered to cope with any challenge.
  • See our Autism Spectrum Disorders (ASD) page for more details on Autism.
* Note that these dosage recommendations apply only to IMMI GcMAF-Forte.